financetom
Business
financetom
/
Business
/
NxGen Brands, Inc. Announces Letter of Intent to Acquire Operating Business
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
NxGen Brands, Inc. Announces Letter of Intent to Acquire Operating Business
Sep 11, 2025 6:11 AM

DENVER, Sept. 11, 2025 (GLOBE NEWSWIRE) -- NxGen Brands, Inc. ( NXGB ) ("NxGen" or the "Company") (www.nxgenbrands.com) is pleased to announce that it has signed an LOI (Letter of Intent) to acquire an operating business that is very scalable in an exciting and growing industry. The company has been a staple in the industry and has a very loyal following that is growing year over year. The company’s unique product offering has garnered attention in retail locations around the US.

Marjorie Schaefer, the Company’s CEO, stated, "I am very pleased to sign this LOI positioning the company with a great opportunity to provide superb value to shareholders and the current employees, and very excited to release more details on the progress of the LOI in the coming weeks!"

To better reflect the company's new direction. Please disregard all past social media posts and/ or news releases. A company press release will verify any new social media outlets. Currently, the only media outlet is the company's X account, @NGen_Brands. In order to better communicate with our shareholders, please email us at [email protected]. The Company's new website is https://www.nxgenbrands.com. All information can be verified at https://www.otcmarkets.com/stock/NXGB/profile. We will be providing many more updates for our shareholders as the company moves in a new direction.

Disclaimer: The Company relies upon the Safe Harbor Laws of 1933, 1934 and 1995 for all public news releases. The company may make forward-looking public statements concerning its expected future operations, performance and other developments. Such forward-looking statements are estimates that reflect the company's best judgment based upon current information. All investments involve risks and uncertainties, and there can be no assurance that other factors will not affect the accuracy of such forward-looking statements. It is impossible to identify all such factors. Factors which could cause actual results to differ materially from those estimated by the company include, but are not limited to, government regulation; managing and maintaining growth; the effect of adverse publicity; litigation; competition; and other factors which may be identify from time to time in the company's public announcements.

Contact: [email protected]

Image: https://www.globenewswire.com/newsroom/ti?nf=OTUyNzIwNSM3MTQxNjQ4IzUwMDE1MDk3OQ==

Image: https://ml.globenewswire.com/media/ZjFmODEzMDItODU3NS00NWRkLWJjOTItZTliZDUwMDUyMGU2LTUwMDE1MDk3OS0yMDI1LTA5LTExLWVu/tiny/NxGen-Brands-Inc-.png

Source: NxGen Brands Inc. ( NXGB )

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Atlassian Insider Sold Shares Worth $1,615,066, According to a Recent SEC Filing
Atlassian Insider Sold Shares Worth $1,615,066, According to a Recent SEC Filing
Apr 5, 2024
09:53 AM EDT, 04/05/2024 (MT Newswires) -- Michael Cannon-brookes, 10% Owner, Director, Co-CEO, Co-Founder, on April 03, 2024, sold 8,241 shares in Atlassian ( TEAM ) for $1,615,066. Following the Form 4 filing with the SEC, Cannon-brookes has control over a total of 490,065 shares of the company, with 490,065 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1650372/000156218024003308/xslF345X03/primarydocument.xml Price: 194.03, Change: +1.71, Percent...
AstraZeneca's Imfinzi improves survival in late-stage lung cancer trial
AstraZeneca's Imfinzi improves survival in late-stage lung cancer trial
Apr 5, 2024
April 5 (Reuters) - AstraZeneca ( AZN ) said on Friday its blockbuster cancer drug Imfinzi helped improve survival in patients in the early stages of an aggressive type of lung cancer, making it the first such immunotherapy to meet two key trial goals. In a late-stage trial, the drug demonstrated statistically significant and clinically meaningful improvement in both overall...
What's Going On With Uber Technologies Shares Friday?
What's Going On With Uber Technologies Shares Friday?
Apr 5, 2024
Uber Technologies ( UBER ), Inc. shares are trading higher in the morning session on Friday. Yesterday, the company entered into a new nationwide partnership with The Vitamin Shoppe, bringing the New Jersey-based health and wellness retailer’s selection to the Uber Eats app. About 700 locations of The Vitamin Shoppe and Super Supplements are now available for ordering on Uber Eats across...
Liberty Energy Insider Sold Shares Worth $903,000, According to a Recent SEC Filing
Liberty Energy Insider Sold Shares Worth $903,000, According to a Recent SEC Filing
Apr 5, 2024
09:44 AM EDT, 04/05/2024 (MT Newswires) -- Christopher A Wright, Director, Chairman of the Board and CEO, around April 03, 2024, sold 40,000 shares in Liberty Energy (LBRT) for $903,000. Following the Form 4 filing with the SEC, Wright has control over a total of 2,858,814 shares of the company, with 2,858,814 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1694028/000169402824000023/xslF345X03/wk-form4_1712270224.xml Price: 22.66,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved